FdaApplication
ANDA 217075
Identifiers
- fda_app_no: ANDA217075
Properties
| Property | Value |
|---|---|
| applicant_name | PADAGIS ISRAEL PHARMACEUTICALS LTD |
| application_type | ANDA |
| approval_date | 2024-07-15 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TAZAROTENE | TAZAROTENE | 0.05% | CREAM;TOPICAL |
1 product